FIELD: biotechnologies.
SUBSTANCE: extracted polypeptide represents a fragment of extracted peptide T101 and consists of amino-acid sequence WWTFFLPSTLWERK, in which at least one amino acid is replaced by the corresponding D-amino acid. The proposed invention can be used in medicine for treatment of autoimmune and/or inflammatory diseases.
EFFECT: invention allows obtaining a polypeptide capable of inducing proliferation of lymphocytes of peripheral blood of a human being, inhibiting growth of a tumour and modulating an immune system.
4 cl, 15 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THYMUS-SPECIFIC PROTEIN | 2005 |
|
RU2398776C2 |
| MEDICATION, INTENDED FOR TREATMENT AND/OR PREVENTION OF AUTOIMMUNE DISEASE AND FOR FORMATION OF REGULATORY N-CELLS | 2009 |
|
RU2531936C2 |
| LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
| RECOMBINANT PROTEIN REC-MP, CONTAINING SEQUENCE OF MYELOPEPTIDES FOR TREATING SECONDARY IMMUNODEFICIENCY CONDITIONS | 2014 |
|
RU2585494C2 |
| GASTROINTESTINAL PROLIFERATIVE FACTOR AND ITS APPLICATIONS | 2005 |
|
RU2343158C2 |
| DRUGS FOR TREATING DISEASES | 2010 |
|
RU2598719C2 |
| MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS | 2013 |
|
RU2724994C2 |
| YEAST-BASED IMMUNOTHERAPEUTIC COMPOSITIONS WITH BRACHYURY | 2012 |
|
RU2690180C2 |
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| IMMUNOTHERAPEUTIC COMPOSITIONS BASED ON YEAST WITH BRACHYURY | 2012 |
|
RU2619850C2 |
